Medicamen group chairman Rahul Bishnoi stated in a press release, "The Company's Vision is to become a most admired Pharmaceutical organisation by offering research & data backed, affordable & quality medicines for the Indian population. To begin with, the company has entered the cardio-vascular & Diabetes (CVD) Business, which contributes annual revenue of more than Rs50,000 crore to IPM with a CAGR of 11%."
Kamal Pahwa, a Pharma Veteran with 32 Years of Experience in the CVD Business, and Pramod Sharma of Neelkanth Drugs Pvt Ltd, India's top distribution network, have joined forces with Medicamen to establish this extremely ambitious initiative, stated Bishnoi.
Medicamen Biotech was founded in 1996 and has since focused on worldwide commerce. It has just started its state-of-the-art oncology factory in Haridwar, which is intended for regulated markets like the United States and Europe. Medicamen released its high-quality cancer drugs in the home market early this year.
For feedback and suggestions, write to us at editorial@iifl.com
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.